Vaccinations in the model drive-thru at pandemic from Covid-19: on report experience
DOI:
https://doi.org/10.33448/rsd-v12i3.40299Keywords:
Vaccination; Covid-19; healthcare personnel.Abstract
Objective: To denote the performance of health professionals in combating Covid-19 inserted in the drive-thru model for mass immunization of the population, demonstrating the result of this action in the city. Methodology: Descriptive study, of the report type of experience of the professionals of the Residency Program in Collective Health in the vaccination against Covid-19, in the drive-thru model in the Centro de Eventos of Ponta Grossa, Paraná. Results: The vaccines used in the immunization against Covid-19 in the municipality, correspond to 4 different laboratories, distributed according to population demand, following the guidelines of each manufacturer, being applied a total of 802,779 doses. The site of choice for vaccination was based on analyses that would facilitate the logistics of the immunization process, avoiding compromising the flow of cars in the city and ensuring the safety of workers. The health professionals worked in the screening stage and in the application of immunizers, with the support of municipal professionals and interns. The implementation of online scheduling and the use of technology also contributed to the organization and agility of the immunization process. Conclusion: This model enabled agility in the application of vaccines, providing comfort to patients, especially those with limitations, and also showed the importance of collective and multiprofessional work.
References
Almeida, L. Y., Domingues, J., Rewa, T., Novaes, D. B., do Nascimento, A. A. A., & Bonfim, D. (2022). Implementação da estratégia drive-through para vacinação COVID-19: um relato de experiência. Revista da Escola de Enfermagem da USP, 56. https://doi.org/10.1590/1980-220X-REEUSP-2021-0397pt
Almeida, S. L. A. C., Oliveira, D. C., de Faria, L. L. F., Godoy, M. C. S., Oliveira, M. M. C., Loch, M. A. L., & Abi-Habib, Y. G. S. (2021). Uma análise crítica das vacinas disponíveis para Sars-cov-2. Brazilian Journal of Health Review, 4(2), 4537-4555. https://doi.org/10.34119/bjhrv4n2-044
Anser, M. K., Yousaf, Z., Khan, M. A., Nassani, A. A., Alotaibi, S. M., Abro, M. M. Q., & Zaman, K. (2020). Does communicable diseases (including COVID-19) may increase global poverty risk? A cloud on the horizon. Environmental Research, 187, 109668. https://doi.org/10.1016/j.envres.2020.109668
Bee, G. R., Pinto, D. D., da Silva, A. C. C. A., Oliveira, T., & da Silva Arrigo, J. (2022). Vacinas contra COVID-19 disponíveis no Brasil. Brazilian Journal of Development, 8(1), 6246-6263. https://doi.org/10.34117/bjdv8n1-422
Brito, S. B. P., Braga, I. O., Cunha, C. C., Palácio, M. A. V., & Takenami, I. (2020). Pandemia da COVID-19: o maior desafio do século XXI. Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia, 8(2), 54-63. https://doi.org/ 10.22239/2317-269X.01531
Brasil. (2023). Vacinometro Covid-19. Ministério da Saúde. Governo Federal. https://infoms.saude.gov.br/extensions/DEMAS_C19_Vacina_v2/DEMAS_C19_Vacina_v2.html
Brasil. (2022a). Plano Nacional de Operacionalização da Vacinação Contra COVID-19. Ministério da Saúde (2). https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/publicacoes-svs/coronavirus/plano-nacional-de-operacionalizacao-da-vacinacao-contra-a-covid-19-pno-2a-edicao-com-isbn
Brasil. (2022b). Plano Estadual de Vacinação Contra a Covid-19. Ministério da Saúde. Governo Federal. (10). https://www.saude.pr.gov.br/sites/default/arquivos_restritos/files/documento/2022-07/plano_estadual_vacinacao_contra_a_covid-19_-_10_ed_11-07-22.pdf.
Conselho Federal de Enfermagem. (2021). Medidas de Prevenção e Controle para Profissionais na Vacinação Contra Covid-19. http://www.cofen.gov.br/medidas-de-prevencao-e-controle-para-profissionais-na-vacinacao-contra-covid-19_84612.html
Coelho, A. C. V. D., Formiga, N. P. F., Lima, M. I. S. D., Sousa, S. M. D. O., Medina, L. L. G., & Silva, L. M. S. D. (2021). Experience of the work of a Nursing team in immunization against Covid-19 using the drive-thru model. Research, Society and Development,10 (15). https://doi.org/10.33448/rsd-v10i15.22661
Fundação Oswaldo Cruz. (2022). Vacinas contra a Covid-19. https://portal.fiocruz.br/vacinascovid19
Galvão, D do N., Tavares, E. C. F., da Silva, L. C., Correia, V. Y. S., Kato, J. S. C., da Silva Castro, L. M., & Bendelaque, D. D. F. R. (2021). Os desafios durante a campanha de vacinação contra COVID-19: um relato de experiência e reflexões. Research, Society and Development, 10(10), e302101018712-e302101018712. https://doi.org/10.33448/rsd-v10i10.18712
Guimarães, R. (2020). Vacinas anticovid: um olhar da saúde coletiva. Ciência & Saúde Coletiva, 25(9), 3579-3585. https://doi.org/10.1590/1413-81232020259.24542020
Instituto Butatan (2021) CoronaVac, vacina de Butantan e da Sinovac, já é usada em mais de 40 países. https://butantan.gov.br/noticias/coronavac-vacina-do-butantan-e-da-sinovac-ja-e-usada-em-mais-de-40-paises.
Lana, R. M., Freitas, L. P., Codeço, C. T., Pacheco, A. G., Carvalho, L. M. F. D., Villela, D. A. M., … & Bastos, L. S. (2021). Identificação de grupos prioritários para a vacinação contra COVID-19 no Brasil. Cadernos de Saúde Pública, 37. https://doi.org/10.1590/0102-311X00049821
Lima, N. T., Buss, P. M., & Sousa, R. P. (2020). A pandemia de COVID-19: uma crise sanitária e humanitária. Cadernos de Saúde Pública, 36(7), e00177020. https://doi.org/10.1590/0102-311X00177020
Oliveira, R. D. C. S., Aranha, M. F. D. A. C., Souza, I. D. N. T. C., Rosa, I. R., Pinheiro, M. A., Gonçalves, M. J., & Júnior, R. L. S. A. (2022). Desenvolvimento de vacinas contra a COVID-19: uma revisão de literatura. Brazilian Journal of Health Review, 5(1), 3473-3492. https://doi.org/10.34119/bjhrv5n1-302
OPAS. (2020). Histórico da Pandemia de Covid 19. https://www.paho.org/pt/covid19/historico-da-pandemia-covid-19
Polo, A. N. N. A., Schiavon, C., Brancher, M., Cian, S., Zallot, C., Pupo, A., & Cinquetti, S. (2020). Drive-through vaccinations prove successful in immunizing mountain communities against tick-borne encephalitis during the COVID-19 pandemic. Journal of Preventive Medicine and Hygiene, 61(4), E497-E500. https://doi.org/10.15167/2421-4248/jpmh2020.61.4.1814
Serpa, F. S., Dortas, S. D., Jr.; Guidacci, M. D. F. R. D. C., Sarinho, F. W., Silva, E. C., Rosario, N. A., Filho; & Campos, R. D. A. (2021). Vacinas COVID-19 e imunobiológicos. Arquivos de Asma, Alergia e Imunologia, 5(2), 126-134. https://docs.bvsalud.org/biblioref/2022/11/1398831/v5n2a06.pdf
Silva, C. M., Soares, R., Machado, W., & Arbilla, G. (2020). A pandemia de covid-19: Vivendo no Antropoceno. Revista Virtual de Química, 12(4), 1001-1016. https://doi.org/10.21577/1984-6835.20200081
Silva, P. S. P., Filho; da Silva, M. J. S, Fortes, E. J.,Jr; Rocha, M. M. L., Araujo, I. A., de Carvalho, I. C. S., & Mesquita, G. V. (2021). Vacinas contra Coronavírus (COVID-19; SARS-COV-2) no Brasil: um panorama geral. Research, society and development, 10(8), e26310817189-e26310817189. https://rsdjournal.org/index.php/rsd/article/view/17189
Silvestre, L. J. R., Mochizuki, L. B., Santos, C. C. D., Santana, A. D. S., Silva, M. C. D., & Silva, F. P. A. D. (2021). Campanha de vacinação da Influenza em meio a pandemia do Coronavírus em Goiás: relato de experiência. Revista Cientifica da Escola Estadual Saúde Pública de Goiás Cândido Santiago, 7000034-7000034. https://www.revista.esap.go.gov.br/index.php/resap/article/view/323/168
Singhal, T. (2020). A review of coronavirus disease-2019 (COVID-19). The indian journal of pediatrics, 87(4), 281-286. https://link.springer.com/content/pdf/10.1007/s12098-020-03263-6.pdf?pdf=button
Souto, E. P., & Kabad, J. (2021). Hesitação vacinal e os desafios para enfrentamento da pandemia de COVID-19 em idosos no Brasil. Revista Brasileira de Geriatria e Gerontologia, 23(5). https://www.scielo.br/j/rbgg/a/4cJkp7RqrBSnd8VJjzmF8bK/?format=pdf&lang=pt
World Health Organization (2020). Framework for decision-making: implementation of mass vaccination campaigns in the context of COVID-19: interim guidance. https://apps.who.int/iris/handle/10665/332159
World Health Organization (2021a). Acesso e alocação: como haverá alocação justa e equitativa de suprimentos limitados? https://www.who.int/pt/news-room/feature-stories/detail/access-and-allocation-how-will-there-be-fair-and-equitable-allocation-of-limited-supplies
World Health Organization (2021b). Os Diferentes Tipos de Vacinas COVID 19. https://www.who.int/pt/news-room/feature-stories/detail/the-race-for-a-covid-19-vaccine-explained
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Lohana Thayna de Souza Prochno; Leticia Naumann; Andressa de Ramos Carneiro; Diego Osmar Rodrigues
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
